In part 2 of this 3-part episode, Jeffrey Kwong, DNP, MPH, ANP-BC, talks about how HIV pre-exposure prophylaxis (PrEP) has evolved over the years since becoming available for use in 2012 and the future of...
In this podcast, Daniel Kuritzkes, MD, speaks about new medications available, choosing a new regimen for, and defining patients with HIV and limited treatment options. Dr Kuritzkez also participated in a...
In part 1 of this 3-part series, Dr Jeffrey Kwong, DNP, MPH, ANP-BC, talks about the barriers patients may have to HIV Pre-exposure Prophylaxis (HIV PrEP)and what clinicians need to know when talking to...
In this podcast, Charles Flexner, MD, speaks about the current state of long-acting agents for the management of patients with HIV, HIV prevention and vaccines, and HIV pathogenesis and cure. Dr Flexner...
In this podcast, Jennifer Sherwood, PhD, and Elise Lankiewicz, MPH, speak about the current state of transgender inclusion in national HIV strategic plans (NSPs) globally, the results from the recent...
In this podcast, Niha Idrees, PharmD, and Melissa Badowski, PharmD, MPH, BCIDP, speak about their team's research evaluating the incidence of hypertension, diabetes, and hyperlipidemia in patients on...
In this podcast, Daniel Lee, MD, answers our questions about dealing with weight gain in patients with HIV, a topic he presented at the ACT HIV 2021 Conference.
In this podcast, Jonathan Karn, PhD, talks about his session "Novel Findings of Neuronal Modulation of HIV Expression in Microglia" at the Conference on Retroviruses and Opportunistic Infections 2021,...
Joshua Khalili, MD, from UCLA, discusses his new paper published in JAMA Internal Medicine, which details the key role primary care practitioners play in prescribing pre-exposure prophylaxis to uninfected...
In this podcast, Sonia Singh, PhD, talks about HIV testing before HIV diagnosis in the Black population in the United States from 2013 to 2018, including ways to help make routine HIV testing more...
